{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:09:14Z","timestamp":1790399354868,"version":"4.1.0"},"reference-count":126,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC\/TRR179 (project no. 272983813)"],"award-info":[{"award-number":["CRC\/TRR179 (project no. 272983813)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC1160\/IMPATH (project no. 256073931)"],"award-info":[{"award-number":["CRC1160\/IMPATH (project no. 256073931)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Heisenberg program (project no. HO 5836\/2-1)"],"award-info":[{"award-number":["Heisenberg program (project no. HO 5836\/2-1)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Health (MOH) Singapore Translational Research","award":["MOH-001633"],"award-info":[{"award-number":["MOH-001633"]}]},{"name":"Ministry of Health (MOH) Singapore Translational Research","award":["MOH-STaR24jan-0004"],"award-info":[{"award-number":["MOH-STaR24jan-0004"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2025,11,13]]},"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:p>Chronic HBV infection remains a major global health burden, with current antiviral therapies effectively suppressing viral replication but rarely achieving functional cure. Adaptive immunity is central to viral clearance but is profoundly impaired during chronic infection. Inducing and enhancing adaptive immunity through therapeutic vaccines, immune checkpoint inhibitors or T cell-based therapies represents a promising approach for HBV cure strategies. However, recent preclinical and clinical studies have demonstrated only limited efficacy, underscoring major immunological challenges. In this review, we summarise current knowledge of the correlates of viral clearance and persistence, discuss key unresolved questions and outline future research directions needed to advance immune-based HBV cure strategies.<\/jats:p>","DOI":"10.1136\/gutjnl-2025-337129","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:35:23Z","timestamp":1764333323000},"page":"1857-1866","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Decoding HBV-specific adaptive immunity: from natural clearance to cure"],"prefix":"10.1136","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1417-4135","authenticated-orcid":false,"given":"Robert","family":"Thimme","sequence":"first","affiliation":[{"name":"Department of Medicine II, Medical Center\u2014University of Freiburg, Freiburg, BW, Germany"},{"name":"University of Freiburg Faculty of Medicine, Freiburg, BW, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8410-8833","authenticated-orcid":false,"given":"Maike","family":"Hofmann","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Medical Center\u2014University of Freiburg, Freiburg, BW, Germany"},{"name":"University of Freiburg Faculty of Medicine, Freiburg, BW, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2942-0485","authenticated-orcid":false,"given":"Antonio","family":"Bertoletti","sequence":"additional","affiliation":[{"name":"Signature Program in Emerging Infectious Diseases, Duke-NUS Graduate Medical School, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0502-2527","authenticated-orcid":false,"given":"Nina","family":"Le Bert","sequence":"additional","affiliation":[{"name":"Signature Program in Emerging Infectious Diseases, Duke-NUS Graduate Medical School, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"2026080602150691000_75.9.1857.1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abi5658"},{"key":"2026080602150691000_75.9.1857.2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116950"},{"key":"2026080602150691000_75.9.1857.3","doi-asserted-by":"publisher","DOI":"10.1038\/nm1096-1104"},{"key":"2026080602150691000_75.9.1857.4","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.02.017"},{"key":"2026080602150691000_75.9.1857.5","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1053\/j.gastro.2017.02.009","article-title":"Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions","volume":"152","author":"Loomba","year":"2017","journal-title":"Gastroenterology"},{"key":"2026080602150691000_75.9.1857.6","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/infdis\/jiz607","article-title":"Single Hepatocyte Hepatitis B Virus Transcriptional Landscape in HIV Coinfection","volume":"221","author":"Balagopal","year":"2020","journal-title":"J Infect Dis"},{"key":"2026080602150691000_75.9.1857.7","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01844-08"},{"key":"2026080602150691000_75.9.1857.8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.06.054"},{"key":"2026080602150691000_75.9.1857.9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0401771101"},{"key":"2026080602150691000_75.9.1857.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.12.015"},{"key":"2026080602150691000_75.9.1857.11","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.15.9369-9380.2005"},{"key":"2026080602150691000_75.9.1857.12","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23361"},{"key":"2026080602150691000_75.9.1857.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.07.014"},{"key":"2026080602150691000_75.9.1857.14","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.01.034"},{"key":"2026080602150691000_75.9.1857.15","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1053\/j.gastro.2018.01.044","article-title":"HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon","volume":"154","author":"Mutz","year":"2018","journal-title":"Gastroenterology"},{"key":"2026080602150691000_75.9.1857.16","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.5.2255-2264.2000"},{"key":"2026080602150691000_75.9.1857.17","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.501122"},{"key":"2026080602150691000_75.9.1857.18","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00554-07"},{"key":"2026080602150691000_75.9.1857.19","doi-asserted-by":"crossref","first-page":"110527","DOI":"10.1016\/j.virol.2025.110527","article-title":"The hepatitis B virus surface antigen: An evolved perfection and its unresolved mysteries","volume":"608","author":"Bell","year":"2025","journal-title":"Virology (Auckl)"},{"key":"2026080602150691000_75.9.1857.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.12.032"},{"key":"2026080602150691000_75.9.1857.21","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02007-17","article-title":"Hepatitis B Virus DNA Integration Occurs Early in the Viral Life Cycle in an In Vitro Infection Model via Sodium Taurocholate Cotransporting Polypeptide-Dependent Uptake of Enveloped Virus Particles","volume":"92","author":"Tu","year":"2018","journal-title":"J Virol"},{"key":"2026080602150691000_75.9.1857.22","doi-asserted-by":"publisher","DOI":"10.3390\/v9040075"},{"key":"2026080602150691000_75.9.1857.23","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/0168-8278(91)90027-9","article-title":"HBcAg and HBeAg expression: how, where, why or why not?","volume":"13 Suppl 4","author":"Will","year":"1991","journal-title":"J Hepatol"},{"key":"2026080602150691000_75.9.1857.24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.17.6599"},{"key":"2026080602150691000_75.9.1857.25","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.immuni.2016.04.008","article-title":"Maternal-Derived Hepatitis B Virus e Antigen Alters Macrophage Function in Offspring to Drive Viral Persistence after Vertical Transmission","volume":"44","author":"Tian","year":"2016","journal-title":"Immunity"},{"key":"2026080602150691000_75.9.1857.26","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.jhep.2025.06.012","article-title":"Rapid whole-blood immune profiling reveals heterogeneous HBV-specific T cell response patterns independent of clinical disease phases","volume":"83","author":"Le Bert","year":"2025","journal-title":"J Hepatol"},{"key":"2026080602150691000_75.9.1857.27","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.1.68-76.2003"},{"key":"2026080602150691000_75.9.1857.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70289-1"},{"key":"2026080602150691000_75.9.1857.29","doi-asserted-by":"publisher","DOI":"10.1126\/science.1691527"},{"key":"2026080602150691000_75.9.1857.30","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.5.1541"},{"key":"2026080602150691000_75.9.1857.31","doi-asserted-by":"publisher","DOI":"10.1038\/nm1317"},{"key":"2026080602150691000_75.9.1857.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.03.005"},{"key":"2026080602150691000_75.9.1857.33","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.19324"},{"key":"2026080602150691000_75.9.1857.34","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.80.7.3532-3540.2006"},{"key":"2026080602150691000_75.9.1857.35","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316644"},{"key":"2026080602150691000_75.9.1857.36","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.04.030"},{"key":"2026080602150691000_75.9.1857.37","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200840","article-title":"Potent human broadly neutralizing antibodies to hepatitis B virus from natural controllers","volume":"217","author":"Hehle","year":"2020","journal-title":"J Exp Med"},{"key":"2026080602150691000_75.9.1857.38","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"3","author":"Yan","year":"2012","journal-title":"Elife"},{"key":"2026080602150691000_75.9.1857.39","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1389"},{"key":"2026080602150691000_75.9.1857.40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1809028115"},{"key":"2026080602150691000_75.9.1857.41","doi-asserted-by":"publisher","DOI":"10.1126\/science.3491425"},{"key":"2026080602150691000_75.9.1857.42","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jhep.2025.03.018","article-title":"EASL Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"83","author":"Cornberg","year":"2025","journal-title":"J Hepatol"},{"key":"2026080602150691000_75.9.1857.43","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1365-2249.1996.d01-732.x","article-title":"Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection","volume":"105","author":"B\u00f6cher","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"2026080602150691000_75.9.1857.44","doi-asserted-by":"publisher","DOI":"10.1172\/JCI121957"},{"key":"2026080602150691000_75.9.1857.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.05.041"},{"key":"2026080602150691000_75.9.1857.46","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.145.10.3442"},{"key":"2026080602150691000_75.9.1857.47","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1620-6"},{"key":"2026080602150691000_75.9.1857.48","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/s41590-025-02199-3","article-title":"CD4+ T cells license Kupffer cells to reverse CD8+ T cell dysfunction induced by hepatocellular priming","volume":"26","author":"Venzin","year":"2025","journal-title":"Nat Immunol"},{"key":"2026080602150691000_75.9.1857.49","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.163600"},{"key":"2026080602150691000_75.9.1857.50","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118902"},{"key":"2026080602150691000_75.9.1857.51","doi-asserted-by":"publisher","DOI":"10.1038\/329547a0"},{"key":"2026080602150691000_75.9.1857.52","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-041015-055318"},{"key":"2026080602150691000_75.9.1857.53","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-024-01097-3"},{"key":"2026080602150691000_75.9.1857.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.06.028"},{"key":"2026080602150691000_75.9.1857.55","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01928-4"},{"key":"2026080602150691000_75.9.1857.56","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316641"},{"key":"2026080602150691000_75.9.1857.57","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-328734"},{"key":"2026080602150691000_75.9.1857.58","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jhep.2024.10.047","article-title":"HBV shows different levels of adaptation to HLA class I-associated selection pressure correlating with markers of replication","volume":"82","author":"Schwarz","year":"2025","journal-title":"J Hepatol"},{"key":"2026080602150691000_75.9.1857.59","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.04.019"},{"key":"2026080602150691000_75.9.1857.60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003490","article-title":"CD40 activation rescues antiviral CD8+ T cells from PD-1-mediated exhaustion","volume":"9","author":"Isogawa","year":"2013","journal-title":"PLoS Pathog"},{"key":"2026080602150691000_75.9.1857.61","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-45612-5","article-title":"A hepatic network of dendritic cells mediates CD4 T cell help outside lymphoid organs","volume":"15","author":"English","year":"2024","journal-title":"Nat Commun"},{"key":"2026080602150691000_75.9.1857.62","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07630-7"},{"key":"2026080602150691000_75.9.1857.63","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20072076"},{"key":"2026080602150691000_75.9.1857.64","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3856"},{"key":"2026080602150691000_75.9.1857.65","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20121172"},{"key":"2026080602150691000_75.9.1857.66","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abi6112","article-title":"Group 1 ILCs regulate T cell-mediated liver immunopathology by controlling local IL-2 availability","volume":"7","author":"Fumagalli","year":"2022","journal-title":"Sci Immunol"},{"key":"2026080602150691000_75.9.1857.67","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/apt.15226","article-title":"Myeloid-derived suppressor cells induce regulatory T cells in chronically HBV infected patients with high levels of hepatitis B surface antigen and persist after antiviral therapy","volume":"49","author":"Pal","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2026080602150691000_75.9.1857.68","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.06.009"},{"key":"2026080602150691000_75.9.1857.69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.07.015"},{"key":"2026080602150691000_75.9.1857.70","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jhep.2020.01.024","article-title":"Hepatitis B core-specific memory B cell responses associate with clinical parameters in patients with chronic HBV","volume":"73","author":"Vanwolleghem","year":"2020","journal-title":"J Hepatol"},{"key":"2026080602150691000_75.9.1857.71","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116497"},{"key":"2026080602150691000_75.9.1857.72","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jhep.2021.07.031","article-title":"Role of anti-HBs in functional cure of HBeAg+ chronic hepatitis B patients infected with HBV genotype A","volume":"76","author":"Xu","year":"2022","journal-title":"J Hepatol"},{"key":"2026080602150691000_75.9.1857.73","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2021.100361","article-title":"Therapeutic vaccine BRII-179 restores HBV-specific immune responses in patients with chronic HBV in a phase Ib\/IIa study","volume":"3","author":"Ma","year":"2021","journal-title":"JHEP Rep"},{"key":"2026080602150691000_75.9.1857.74","doi-asserted-by":"crossref","first-page":"8585","DOI":"10.1016\/j.vaccine.2007.09.072","article-title":"Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: a randomized, controlled study of co-administration of HBsAg\/AS02 candidate vaccine and lamivudine","volume":"25","author":"Vandepapeli\u00e8re","year":"2007","journal-title":"Vaccine (Auckl)"},{"key":"2026080602150691000_75.9.1857.75","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/j.gastro.2025.02.016","article-title":"The Impact of Hepatitis B Surface Antigen Reduction via Small Interfering RNA Treatment on Natural and Vaccine (BRII-179)-Induced Hepatitis B Virus-Specific Humoral and Cellular Immune Responses","volume":"169","author":"Ji","year":"2025","journal-title":"Gastroenterology"},{"key":"2026080602150691000_75.9.1857.76","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.80.6.2968-2975.2006"},{"key":"2026080602150691000_75.9.1857.77","doi-asserted-by":"publisher","DOI":"10.1086\/513296"},{"key":"2026080602150691000_75.9.1857.78","doi-asserted-by":"publisher","DOI":"10.1172\/JCI121960"},{"key":"2026080602150691000_75.9.1857.79","doi-asserted-by":"crossref","unstructured":"Vincenzetti L , Wong R , Marzi R , et al . Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cells. J Hepatol 2025. doi:10.1016\/j.jhep.2025.08.016","DOI":"10.1101\/2025.01.13.25320453"},{"key":"2026080602150691000_75.9.1857.80","doi-asserted-by":"crossref","first-page":"105893","DOI":"10.1016\/j.antiviral.2024.105893","article-title":"Current and future use of antibody-based passive immunity to prevent or control HBV\/HDV infections","volume":"226","author":"Gehring","year":"2024","journal-title":"Antiviral Res"},{"key":"2026080602150691000_75.9.1857.81","doi-asserted-by":"publisher","DOI":"10.1016\/0270-9139(93)90003-6"},{"key":"2026080602150691000_75.9.1857.82","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510250631"},{"key":"2026080602150691000_75.9.1857.83","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.07.014"},{"key":"2026080602150691000_75.9.1857.84","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-00817-w"},{"key":"2026080602150691000_75.9.1857.85","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2021.100388","article-title":"Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infection","volume":"4","author":"van Buuren","year":"2022","journal-title":"JHEP Rep"},{"key":"2026080602150691000_75.9.1857.86","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-332526"},{"key":"2026080602150691000_75.9.1857.87","doi-asserted-by":"publisher","DOI":"10.1084\/jem.191.8.1269"},{"key":"2026080602150691000_75.9.1857.88","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317071"},{"key":"2026080602150691000_75.9.1857.89","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20162115"},{"key":"2026080602150691000_75.9.1857.90","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.02.017"},{"key":"2026080602150691000_75.9.1857.91","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220780","article-title":"SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8+ and CD4+ T cells of broad specificity","volume":"219","author":"Lim","year":"2022","journal-title":"J Exp Med"},{"key":"2026080602150691000_75.9.1857.92","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41586-022-05645-6","article-title":"Tissue CD14+CD8+ T cells reprogrammed by myeloid cells and modulated by LPS","volume":"614","author":"Pallett","year":"2023","journal-title":"Nature New Biol"},{"key":"2026080602150691000_75.9.1857.93","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314873"},{"key":"2026080602150691000_75.9.1857.94","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200921","article-title":"Circulating clonally expanded T cells reflect functions of tumor-infiltrating T cells","volume":"218","author":"Lucca","year":"2021","journal-title":"J Exp Med"},{"key":"2026080602150691000_75.9.1857.95","doi-asserted-by":"publisher","DOI":"10.1172\/JCI92812"},{"key":"2026080602150691000_75.9.1857.96","doi-asserted-by":"publisher","DOI":"10.1172\/JCI3731"},{"key":"2026080602150691000_75.9.1857.97","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(03)00292-7"},{"key":"2026080602150691000_75.9.1857.98","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000694","article-title":"HBV-specific T-cell function is nonenhanced by tenofovir-induced decline in HBV viremia or HBsAg titer in chronic hepatitis B","volume":"9","author":"Traum","year":"2025","journal-title":"Hepatol Commun"},{"key":"2026080602150691000_75.9.1857.99","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.02.032"},{"key":"2026080602150691000_75.9.1857.100","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.11.007"},{"key":"2026080602150691000_75.9.1857.101","doi-asserted-by":"publisher","DOI":"10.1172\/JCI29832"},{"key":"2026080602150691000_75.9.1857.102","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1016\/j.jhep.2023.05.032","article-title":"Comment on \u201cEnd-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB\u201d","volume":"79","author":"Bertoletti","year":"2023","journal-title":"J Hepatol"},{"key":"2026080602150691000_75.9.1857.103","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.01.021"},{"key":"2026080602150691000_75.9.1857.104","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jhep.2024.06.033","article-title":"Varied immune responses of HBV-specific B cells in patients undergoing pegylated interferon-alpha treatment for chronic hepatitis B","volume":"81","author":"Zhang","year":"2024","journal-title":"J Hepatol"},{"key":"2026080602150691000_75.9.1857.105","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2405485"},{"key":"2026080602150691000_75.9.1857.106","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.01.032"},{"key":"2026080602150691000_75.9.1857.107","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1053\/j.gastro.2018.01.030","article-title":"TLR7 Agonist Increases Responses of Hepatitis B Virus-Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues","volume":"154","author":"Boni","year":"2018","journal-title":"Gastroenterology"},{"key":"2026080602150691000_75.9.1857.108","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/hep4.1420","article-title":"Fine-Tuning TLR-7-Based Therapy for Functional HBV Cure","volume":"3","author":"Bertoletti","year":"2019","journal-title":"Hepatol Commun"},{"key":"2026080602150691000_75.9.1857.109","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/j.gastro.2019.03.044","article-title":"Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis","volume":"157","author":"Boni","year":"2019","journal-title":"Gastroenterology"},{"key":"2026080602150691000_75.9.1857.110","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.06.027"},{"key":"2026080602150691000_75.9.1857.111","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-021-00776-0","article-title":"Restoration of HBV-specific CD8+ T-cell responses by sequential low-dose IL-2 treatment in non-responder patients after IFN-\u03b1 therapy","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"2026080602150691000_75.9.1857.112","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adi1572","article-title":"CD8 cis-targeted IL-2 drives potent antiviral activity against hepatitis B virus","volume":"16","author":"Andreata","year":"2024","journal-title":"Sci Transl Med"},{"key":"2026080602150691000_75.9.1857.113","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108666","article-title":"IL-15 boosts activated HBV core-specific CD8+ progenitor cells via metabolic rebalancing in persistent HBV infection","volume":"27","author":"Pe\u00f1a-Asensio","year":"2024","journal-title":"iScience"},{"key":"2026080602150691000_75.9.1857.114","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/infdis\/jiy576","article-title":"Interleukin 21 Reinvigorates the Antiviral Activity of Hepatitis B Virus (HBV)-Specific CD8+ T Cells in Chronic HBV Infection","volume":"219","author":"Tang","year":"2019","journal-title":"J Infect Dis"},{"key":"2026080602150691000_75.9.1857.115","doi-asserted-by":"publisher","DOI":"10.1172\/JCI93024"},{"key":"2026080602150691000_75.9.1857.116","doi-asserted-by":"publisher","DOI":"10.1172\/JCI120228"},{"key":"2026080602150691000_75.9.1857.117","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1053\/j.gastro.2015.11.050","article-title":"Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B","volume":"150","author":"Park","year":"2016","journal-title":"Gastroenterology"},{"key":"2026080602150691000_75.9.1857.118","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau6905","article-title":"Multifactorial heterogeneity of virus-specific T cells and association with the progression of human chronic hepatitis B infection","volume":"4","author":"Cheng","year":"2019","journal-title":"Sci Immunol"},{"key":"2026080602150691000_75.9.1857.119","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4275"},{"key":"2026080602150691000_75.9.1857.120","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-329437"},{"key":"2026080602150691000_75.9.1857.121","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jhep.2022.03.028","article-title":"The challenges of adopting immunological biomarkers in the management of chronic HBV infection","volume":"77","author":"Bertoletti","year":"2022","journal-title":"J Hepatol"},{"key":"2026080602150691000_75.9.1857.122","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jhep.2022.02.020","article-title":"Immunological biomarker discovery in cure regimens for chronic hepatitis B virus infection","volume":"77","author":"Gehring","year":"2022","journal-title":"J Hepatol"},{"key":"2026080602150691000_75.9.1857.123","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-327202"},{"key":"2026080602150691000_75.9.1857.124","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.05.004"},{"key":"2026080602150691000_75.9.1857.125","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-325915"},{"key":"2026080602150691000_75.9.1857.126","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000524"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2025-337129","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T09:15:42Z","timestamp":1786007742000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2025-337129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":126,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,8,6]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1136\/gutjnl-2025-337129"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2025-337129","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]}}}